Association of Bcl-2 with misfolded prion protein is linked to the toxic potential of cytosolic PrP

Molecular Biology of the Cell

Volumn 17, Issue 8, 2006, Pages 3356-3368

  Rambold, Angelika S ^a   Miesbauer, Margit ^a   Rapaport, Doron ^a   Bartke, Till ^b   Baier, Michael ^c   Winklhofer, Konstanze F ^a   Tatzelt, Jörg ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHAPERONE; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; POLYGLUTAMINE; PRION PROTEIN; PROTEIN; PROTEIN BCL 2; PROTEINASE K;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRION DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN LOCALIZATION; PROTEIN MISFOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING;

ANIMALS; APOPTOSIS; CELL COMPARTMENTATION; CELLS, CULTURED; CYTOSOL; HUMANS; HYDROPHOBICITY; MICE; MICE, INBRED C57BL; MOLECULAR CHAPERONES; MUTATION; PRION DISEASES; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; PRPC PROTEINS;

EID: 33746615107     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-01-0083     Document Type: Article

References (44)

1. Aguzzi, A., and Polymenidou, M. (2004). Mammalian prion biology: one century of evolving concepts. Cell 116, 313-327.
2. Bartke, T., Pohl, C., Pyrowolakis, G., and Jentsch, S. (2004). Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol. Cell 14, 801-811.
3. Blochberger, T. C., Cooper, C., Peretz, D., Tatzelt, J., Griffith, O. H., Baldwin, M. A., and Prusiner, S. B. (1997). Prion protein expression in Chinese hamster ovary cells using a glutamine synthetase selection and amplification system. Protein Eng. 10, 1465-1473.
4. Bragason, B. T., and Palsdottir, A. (2005). Interaction of PrP with NRAGE, a protein involved in neuronal apoptosis. Mol. Cell. Neurosci. 29, 232-244.
5. Chesebro, B. (2003). Introduction to the transmissible spongiform encephalopathies or prion diseases. Br. Med. Bull. 66, 1-20.
6. Chesebro, B. et al. (2005). Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439.
7. Collinge, J. (2001). Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24, 519-550.
8. Danial, N. N., and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116, 205-219.
9. Fioriti, L., Dossena, S., Stewart, L. R., Stewart, R. S., Harris, D. A., Forloni, G., and Chiesa, R. (2005). Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations. J. Biol. Chem. 280, 11320-11328.
10. Hegde, R. S., Mastrianni, J. A., Scott, M. R, DeFea, K. A., Tremblay, P., Torchia, M., DeArmond, S. J., Prusiner, S. B., and Lingappa, V. R. (1998). A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834.
11. Hegde, R. S., Tremblay, P., Groth, D., DeArmond, S. J., Prusiner, S. B., and Lingappa, V. R. (1999). Transmissible and genetic prion diseases share a common pathway of neurodegeneration [see comments]. Nature 402, 822-826.
12. Heller, U., Winklhofer, K. F., Heske, J., Reintjes, A., and Tatzelt, J. (2003). Post-translational import of the prion protein into the endoplasmic reticulum interferes with cell viability: a critical role for the putative transmembrane domain. J. Biol. Chem. 278, 36139-36147.
13. Henn, I. H., Gostner, J. M., Tatzelt, J., and Winklhofer, K. F. (2005). Pathogenic mutations inactivate parkin by distinct mechanisms. J. Neurochem. 92, 114-122.
14. Heske, J., Heller, U., Winklhofer, K. F., and Tatzelt, J. (2004). The C-terminal domain of the prion protein is necessary and sufficient for import into the endoplasmic reticulum. J. Biol. Chem. 279, 5435-5443.
15. Hetz, C., Russelakis-Carneiro, M., Maundrell, K., Castilla, J., and Soto, C. (2003). Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein. EMBO J. 22, 5435-5445.
16. Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., and Diringer, H. (1987). Mouse polyclonal and mAb to scrapie-associated fibril proteins. J. Virol. 61, 3688-3693.
17. Kim, S., Nollen, E. A., Kitagawa, K., Bindokas, V. P., and Morimoto, R. I. (2002). Polyglutamine protein aggregates are dynamic. Nat. Cell. Biol. 4, 826-831.
18. Krasemann, S., Groschup, M. H., Harmeyer, S., Hunsmann, G., and Bodemer, W. (1996). Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice. Mol. Med. 2, 725-734.
19. Kristiansen, M., Messenger, M. J., Klohn, P.C., Brandner, S., Wadsworth, J. D., Collinge, J., and Tabrizi, S. J. (2005). Disease-related prion protein forms aggresomes in neuronal cells leading to caspase-activation and apoptosis. J. Biol. Chem. Sep 12; Epub ahead of print.
20. Kurschner, C., and Morgan, J. I. (1995). The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res. Mol. Brain Res. 30, 165-168.
21. Kurschner, C., and Morgan, J. I. (1996). Analysis of interaction sites in homo- and heteromeric complexes containing Bcl-2 family members and the cellular prion protein. Brain Res. Mol. Brain Res. 37, 249-258.
22. Lin, B., Kolluri, S. K., Lin, F., Liu, W., Han, Y. H., Cao, X., Dawson, M. I., Reed, J. C., and Zhang, X. K. (2004). Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116, 527-540.
23. Ma, J., and Lindquist, S. (2001). Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. USA 98, 14955-14960.
24. Ma, J., Wollmann, R., and Lindquist, S. (2002). Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298, 1781-1785.
25. Mironov, A. J., Latawiec, D., Wille, H., Bouzamondo-Bernstein, E., Legname, G., Williamson, R. A., Burton, D., DeArmond, S. J., Prusiner, S. B., and Peters, P. J. (2003). Cytosolic prion protein in neurons. J. Neurosci. 23, 7183-7193.
26. Pasinelli, P., Belford, M. E., Lennon, N., Bacskai, B. J., Hyman, B. T., Trott, I. D., and Brown, R. H. (2004). Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron 43, 19-30.
27. Prusiner, S. B., Scott, M. R., DeArmond, S. J., and Cohen, F. E. (1998). Prion protein biology. Cell 93, 337-348.
28. Rane, N. S., Yonkovich, J. L., and Hegde, R. S. (2004). Protection from cytosolic prion protein toxicity by modulation of protein translocation. EMBO J. 23, 4550-4559.
29. Rogers, M., Yehiely, F., Scott, M., and Prusiner, S. B. (1993). Conversion of truncated and elongated prion proteins into the scrapie isoform in cultured cells. Proc. Natl. Acad. Sci. USA 90, 3182-3186.
30. Roucou, X., Guo, Q., Zhang, Y., Goodyer, C. G., and LeBlanc, A. C. (2003). Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J. Biol. Chem. 278, 40877-40881.
31. Schultz, J., Schwarz, A., Neidhold, S., Burwinkel, M., Riemer, C., Simon, D., Kopf, M., Otto, M., and Baier, M. (2004). Role of interleukin-1 in prion disease-associated astrocyte activation. Am. J. Pathol. 165, 671-678.
32. Stan, T., Brix, J., Schneider-Mergener, J., Pfanner, N., Neupert, W., and Rapaport, D. (2003). Mitochondrial protein import: recognition of internal import signals of BCS1 by the TOM complex. Mol. Biol. Cell. 23, 2239-2250.
33. Stewart, R. S., Piccardo, P., Ghetti, B., and Harris, D. A. (2005). Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J. Neurosci. 25, 3469-3477.
34. Tatzelt, J., Prusiner, S. B., and Welch, W. J. (1996). Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J. 15, 6363-6373.
35. Tatzelt, J., and Winklhofer, K. F. (2004). Folding and misfolding of the prion protein in the secretory pathway. Amyloid 11, 162-172.
36. Weissmann, C., Fischer, M., Raeber, A., Büeler, H., Sailer, A., Shmerling, D., Rülicke, T., Brandner, S., and Aguzzi, A. (1996). The role of PrP in pathogenesis of experimental scrapie. Cold Spring Harb. Symp. Quant. Biol. 61, 511-522.
37. Winklhofer, K. F., Heller, U., Reintjes, A., and Tatzelt, J. (2003a). Inhibition of complex glycosylation increases formation of PrPSc. Traffic 4, 313-322.
38. Winklhofer, K. F., Henn, I. H., Kay-Jackson, P., Heller, U., and Tatzelt, J. (2003b). Inactivation of parkin by oxidative stress and C-terminal truncations; a protective role of molecular chaperones. J. Biol. Chem. 278, 47199-47208.
39. Winklhofer, K. F., Heske, J., Heller, U., Reintjes, A., Muranji, W., Moarefi, I., and Tatzelt, J. (2003c). Determinants of the in vivo-folding of the prion protein: a bipartite function of helix 1 in folding and aggregation. J. Biol. Chem. 278, 14961-14970.
40. Winklhofer, K. F., and Tatzelt, J. (2000). Cationic lipopolyamines induce degradation of PrPSc in scrapie-infected mouse neuroblastoma cells. Biol. Chem. 381, 463-469.
41. Winklhofer, K. F., and Tatzelt, J. (2006). The role of chaperones in Parkinson's disease and prion diseases. In: Molecular Chaperones in Health and Diseases, Vol. 172, ed. M. Gaestel, New York: Springer-Verlag, 221-258.
42. Yedidia, Y., Horonchik, L., Tzaban, S., Yanai, A., and Taraboulos, A. (2001). Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein. EMBO J. 20, 5383-5391.
43. Yost, C. S., Lopez, C. D., Prusiner, S. B., Myers, R. M., and Lingappa, V. R. (1990). Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 343, 669-672.
44. Zanusso, G., Petersen, R. B., Jin, T., Jing, Y., Kanoush, R., Ferrari, S., Gambetti, P., and Singh, N. (1999). Proteasomal degradation and N-terminal protease resistance of the codon 145 mutant prion protein. J. Biol. Chem. 274, 23396-23404.